Teva Pharmaceutical Industries Ltd (TEVA)

3,463.00
0.00(0.00%)
  • Volume:
    0
  • Bid/Ask:
    3,461.00/3,463.00
  • Day's Range:
    3,456.00 - 3,525.00

TEVA Overview

Prev. Close
3,525
Day's Range
3,456-3,525
Revenue
53.21B
Open
3,525
52 wk Range
2,879-4,529
EPS
-11.83
Volume
0
Market Cap
37.98B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
915,869
P/E Ratio
-
Beta
1.5
1-Year Change
-14.83%
Shares Outstanding
1,096,776,176
Next Earnings Date
Aug 05, 2021
What is your sentiment on Teva Pharmaceutical Industries Ltd?
or
Vote to see community's results!

Teva Pharmaceutical Industries Ltd News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong SellStrong SellStrong SellSell
Technical IndicatorsStrong SellStrong SellStrong SellBuySell
SummaryStrong SellStrong SellStrong SellNeutralSell

Teva Pharmaceutical Industries Ltd Company Profile

Teva Pharmaceutical Industries Ltd Company Profile

Employees
39717
Market
Israel

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.

Read More
  • nice move against nasdaq on last friday
    0
    • hello Associates & Partners I sold at 10.45 $ and now I am looking to entry in NGM , MYOVANT or MERSANA what which is your impact and your opinion which equity will go better for short term? please if anybody knows let me know your precious feedback, Szilike.
      0
      • good news. teva will sell malaria cure against the corrona virus
        1
        • I personally know someone who used it and it worked very well. They are going to see some big volumes even if they have competition. When you're dealing with these quantities, everyone makes money.
          1
      • when the Dow drops 900 points and Teva is up, that's a really good sign of strength.
        0
        • buy?
          0
          • Yep, they have the main drug to treat the plague, and they are already restructured and doing well.
            0
        • buy?
          0
          • after 3 long hard years, TEVA is finally found the bottom.. better years ahead for the company and the stock. this will be one mighty comeback! "a wounded lion is still a lion"...
            0
            • even if he offeres the lioness a ***
              0
          • Pe of 3, that is cheap !! End Aug court judgement in USA.trump will influence the judge to be lenient, fine $900 mln, and stock will double.
            0
            • not sure he has enough power to influence on court
              0
          • !!
            1
            • it looks good
              0
              • lol
                0
            • is it good to buy here??
              0
              • Yes. Obviously... but only as a long term investment...
                0
              • Yes. Obviously... but only as a long term investment...
                0
            • The same rollercoaster
              0
              • Going down
                1
                • Terrible performance vs. Expectation to atleast follow
                  0
              • Test
                2
                • ok
                  0
              • Test
                3
                • Ok
                  0
              • Test
                1
                Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.